Potential therapeutic agents in the management of organophosphorus poisoning.
Sivagnanam
Soupramanien
S
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000818:Animals; D001285:Atropine / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D006801:Humans; D007306:Insecticides / Q000506:poisoning*; D008274:Magnesium / Q000627:therapeutic use; D051379:Mice; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009943:Organophosphorus Compounds; D011041:Poisoning / Q000188:drug therapy; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D012969:Sodium Fluoride / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D007306:Insecticides; D018727:Muscarinic Antagonists; D009943:Organophosphorus Compounds; D011220:Pralidoxime Compounds; D001285:Atropine; D012969:Sodium Fluoride; D008274:Magnesium; D003000:Clonidine